PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer

Teruyuki Sato, Atsushi Kaneda, Shingo Tsuji, Takayuki Isagawa, Shogo Yamamoto, Takanori Fujita, Ryota Yamanaka, Yukiko Tanaka, Toshihiro Nukiwa, Victor E. Marquez, Yuichi Ishikawa, Masakazu Ichinose, Hiroyuki Aburatani

Research output: Contribution to journalArticlepeer-review

86 Citations (Scopus)

Abstract

Small cell lung cancer (SCLC) is a subtype of lung cancer with poor prognosis. Expression array analysis of 23 SCLC cases and 42 normal tissues revealed that EZH2 and other PRC2 members were highly expressed in SCLC. ChIP-seq for H3K27me3 suggested that genes with H3K27me3(+) in SCLC were extended not only to PRC2-target genes in ES cells but also to other target genes such as cellular adhesion-related genes. These H3K27me3(+) genes in SCLC were repressed significantly, and introduction of the most repressed gene JUB into SCLC cell line lead to growth inhibition. Shorter overall survival of clinical SCLC cases correlated to repression of JUB alone, or a set of four genes including H3K27me3(+) genes. Treatment with EZH2 inhibitors, DZNep and GSK126, resulted in growth repression of SCLC cell lines. High PRC2 expression was suggested to contribute to gene repression in SCLC, and may play a role in genesis of SCLC.

Original languageEnglish
Article number1911
JournalScientific reports
Volume3
DOIs
Publication statusPublished - 2013

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer'. Together they form a unique fingerprint.

Cite this